Last reviewed · How we verify
Carogra (Carotegrast methyl)
Carogra (generic name: Carotegrast methyl) is a Small molecule drug developed by EA Pharma Co., Ltd.. It is currently FDA-approved for Ulcerative colitis.
Carotegrast methyl is a medication used to treat ulcerative colitis. Its mechanism of action is not specified in the provided information.
At a glance
| Generic name | Carotegrast methyl |
|---|---|
| Sponsor | EA Pharma Co., Ltd. |
| Target | Integrin alpha-4/beta-1 |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Ulcerative colitis
Common side effects
Key clinical trials
- Carotegrast Methyl in Ulcerative Colitis (PHASE4)
- A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carogra CI brief — competitive landscape report
- Carogra updates RSS · CI watch RSS
- EA Pharma Co., Ltd. portfolio CI
Frequently asked questions about Carogra
What is Carogra?
Carogra (Carotegrast methyl) is a Small molecule drug developed by EA Pharma Co., Ltd., indicated for Ulcerative colitis.
What is Carogra used for?
Carogra is indicated for Ulcerative colitis.
Who makes Carogra?
Carogra is developed and marketed by EA Pharma Co., Ltd. (see full EA Pharma Co., Ltd. pipeline at /company/ea-pharma-co-ltd).
What is the generic name of Carogra?
Carotegrast methyl is the generic (nonproprietary) name of Carogra.
What development phase is Carogra in?
Carogra is FDA-approved (marketed).
What does Carogra target?
Carogra targets Integrin alpha-4/beta-1.
Related
- Target: All drugs targeting Integrin alpha-4/beta-1
- Manufacturer: EA Pharma Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Ulcerative colitis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing